Stem Cells Treatment of Complex Crohn's Anal Fistula

University of Southern Denmark13 enrolled

Overview

A pilot study to investigate the safety and feasibility of stem cells treatment of complex anal fistula in patients with Crohn's disease.

Stem cells therapy in the management of soft tissue healing has been shown to be safe and feasible with encouraging short-term results both for crypto glandular and Crohns anal fistula. The long-term results are still insufficient but based on only a few studies conducted with small patient series and various techniques and type of stem cells. In the present study the patient's own adipose tissue derived regenerative cells (ADRCs) will be used. Traditionally the stem cells are injected into the fistula tract; however survival and retaining the stem cells in the fistula tract is problematic. Alternatively, one may apply stem cells enriched fatty tissue around and into the fistula tract. The aim of this project is to develop a method for treatment of patients with Crohns fistula. The results of conventional surgery are disappointing and followed by a high degree of recurrence and complications.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Anal Fistula Crohn Disease

Interventions

stem cells injectionPROCEDURE

two surgical interventions as day-surgery, starting with liposuction from the abdomen (about 200-300 ml), and fistula tract debridement and closure of internal opening. The external opening is excised. About 30-40 ml fresh harvested patients own fatty tissue are then injected with large needle around the fistula from internal til external opening.The resting harvested fatty tissue will be sent to stem cells (Adipose Derived Regenrative Cells ADRCs) isolation, using Cytori Celusion system®. When the stem cells isolation is completed, 4ml concentrated stem cells ( contains around 20-40 millions cells ) will be injected around the prepared fistula tract, the same site where the fresh harvested fatty tissue injected before.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with Crohn's anal fistulas and\> 18 yrs old. Exclusion Criteria: * Signs of suppuration around the fistula * Active intestinal Crohn disease not in remission * Malignancy within 5 years * Previous radiotherapy of the abdomen and pelvis * BMI under 18.5 * Coagulopathy * Fistula with side branches * Low anal fistula * Verified syphilis, HIV, or hepatitis on screening test.

Locations (1)

Odense University Hospital

Odense, Denmark

Outcomes

Primary Outcomes

healing

closure of the fistula with no secretions

Time frame: 6 months

Secondary Outcomes

recurrence

recurrence of the fistula

Time frame: 6 months

time to healing

time required to healing of the fistula

Time frame: 6 months

major adverse effects

occurrence of infections, sepsis bleeding and allergy.

Time frame: 6 months

radiological healing

Changes on MRI scanning

Time frame: at 6 months

functional outcome

changes in Wexner incontinence score

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.